Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Optical Imaging | 2 | 2017 | 48 | 0.580 |
Why?
|
| Positron-Emission Tomography | 5 | 2018 | 329 | 0.550 |
Why?
|
| Implants, Experimental | 1 | 2013 | 16 | 0.450 |
Why?
|
| Luminescent Measurements | 1 | 2013 | 57 | 0.450 |
Why?
|
| Peritoneum | 1 | 2013 | 57 | 0.440 |
Why?
|
| Molecular Imaging | 1 | 2013 | 64 | 0.420 |
Why?
|
| Nanoparticles | 5 | 2017 | 157 | 0.380 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2013 | 138 | 0.300 |
Why?
|
| Image Enhancement | 2 | 2007 | 563 | 0.250 |
Why?
|
| Transducers | 1 | 2004 | 41 | 0.250 |
Why?
|
| Neural Stem Cells | 2 | 2015 | 58 | 0.240 |
Why?
|
| Silicon Dioxide | 2 | 2017 | 39 | 0.240 |
Why?
|
| Glioblastoma | 2 | 2015 | 255 | 0.210 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2004 | 579 | 0.180 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2004 | 663 | 0.170 |
Why?
|
| Brain Neoplasms | 2 | 2015 | 763 | 0.170 |
Why?
|
| Hypertension, Pulmonary | 2 | 2013 | 346 | 0.160 |
Why?
|
| 4-Aminopyridine | 1 | 2018 | 32 | 0.160 |
Why?
|
| Fluorine Radioisotopes | 1 | 2018 | 25 | 0.160 |
Why?
|
| Luminescence | 1 | 2017 | 16 | 0.160 |
Why?
|
| Demyelinating Diseases | 1 | 2018 | 68 | 0.160 |
Why?
|
| Algorithms | 2 | 2007 | 1830 | 0.150 |
Why?
|
| Lectins | 1 | 2017 | 84 | 0.150 |
Why?
|
| Mice, Nude | 3 | 2015 | 790 | 0.150 |
Why?
|
| Mice | 10 | 2018 | 11352 | 0.140 |
Why?
|
| Colonic Polyps | 1 | 2017 | 126 | 0.140 |
Why?
|
| Lung Neoplasms | 3 | 2015 | 2262 | 0.140 |
Why?
|
| Materials Testing | 2 | 2013 | 91 | 0.130 |
Why?
|
| Precancerous Conditions | 1 | 2017 | 196 | 0.130 |
Why?
|
| Potassium Channels | 1 | 2018 | 340 | 0.130 |
Why?
|
| Fractals | 1 | 2015 | 42 | 0.130 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2015 | 92 | 0.130 |
Why?
|
| Cell Line, Tumor | 4 | 2015 | 2426 | 0.130 |
Why?
|
| Phantoms, Imaging | 4 | 2017 | 429 | 0.130 |
Why?
|
| Multimodal Imaging | 2 | 2015 | 110 | 0.130 |
Why?
|
| Endoscopy | 1 | 2017 | 332 | 0.120 |
Why?
|
| Chelating Agents | 1 | 2013 | 69 | 0.110 |
Why?
|
| Polyvinyl Chloride | 1 | 2013 | 8 | 0.110 |
Why?
|
| GTP Phosphohydrolases | 1 | 2013 | 71 | 0.110 |
Why?
|
| Organometallic Compounds | 1 | 2013 | 132 | 0.110 |
Why?
|
| Mitochondrial Dynamics | 1 | 2013 | 53 | 0.110 |
Why?
|
| Animals | 12 | 2018 | 26582 | 0.110 |
Why?
|
| Abdomen | 1 | 2013 | 122 | 0.110 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2011 | 1075 | 0.110 |
Why?
|
| Mitochondrial Proteins | 1 | 2013 | 123 | 0.110 |
Why?
|
| Heat-Shock Proteins | 1 | 2013 | 179 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2013 | 2232 | 0.100 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2012 | 108 | 0.100 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2010 | 23 | 0.100 |
Why?
|
| Receptors, Opioid, mu | 1 | 2010 | 45 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 860 | 0.090 |
Why?
|
| Tumor Burden | 1 | 2011 | 289 | 0.090 |
Why?
|
| Monitoring, Physiologic | 1 | 2012 | 268 | 0.090 |
Why?
|
| Lung Injury | 1 | 2010 | 47 | 0.090 |
Why?
|
| Simvastatin | 1 | 2010 | 106 | 0.090 |
Why?
|
| Drug Carriers | 1 | 2010 | 81 | 0.090 |
Why?
|
| Disease Progression | 2 | 2012 | 1531 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 938 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 1204 | 0.090 |
Why?
|
| Radiation Injuries | 1 | 2010 | 155 | 0.080 |
Why?
|
| Spiral Cone-Beam Computed Tomography | 1 | 2007 | 7 | 0.080 |
Why?
|
| Lung | 2 | 2013 | 1170 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 378 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2013 | 1565 | 0.070 |
Why?
|
| Liver | 1 | 2010 | 1230 | 0.060 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2004 | 33 | 0.060 |
Why?
|
| Equipment Failure Analysis | 1 | 2004 | 90 | 0.060 |
Why?
|
| Fourier Analysis | 1 | 2004 | 125 | 0.060 |
Why?
|
| Rats | 3 | 2018 | 3990 | 0.060 |
Why?
|
| Information Storage and Retrieval | 1 | 2004 | 120 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2017 | 1041 | 0.060 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2004 | 201 | 0.060 |
Why?
|
| Equipment Design | 1 | 2004 | 406 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 2705 | 0.060 |
Why?
|
| Radiopharmaceuticals | 2 | 2015 | 180 | 0.060 |
Why?
|
| Humans | 11 | 2018 | 86643 | 0.050 |
Why?
|
| Fluorescent Dyes | 2 | 2017 | 242 | 0.050 |
Why?
|
| Familial Primary Pulmonary Hypertension | 2 | 2013 | 60 | 0.050 |
Why?
|
| Female | 6 | 2018 | 44532 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 1920 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 2601 | 0.050 |
Why?
|
| Drug Delivery Systems | 2 | 2013 | 178 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 2903 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2013 | 1219 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 1991 | 0.040 |
Why?
|
| Radioactive Tracers | 1 | 2018 | 6 | 0.040 |
Why?
|
| Calibration | 1 | 2017 | 99 | 0.040 |
Why?
|
| Mice, Inbred A | 1 | 2017 | 23 | 0.040 |
Why?
|
| X-Rays | 1 | 2017 | 130 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2017 | 96 | 0.040 |
Why?
|
| Apoptosis | 2 | 2013 | 1683 | 0.040 |
Why?
|
| Indium Radioisotopes | 1 | 2015 | 10 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 2015 | 51 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2015 | 290 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2018 | 459 | 0.030 |
Why?
|
| Colonoscopy | 1 | 2017 | 264 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2010 | 3092 | 0.030 |
Why?
|
| Nanomedicine | 1 | 2013 | 14 | 0.030 |
Why?
|
| Colon | 1 | 2017 | 496 | 0.030 |
Why?
|
| Optic Atrophy, Autosomal Dominant | 1 | 2013 | 4 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 16 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 134 | 0.030 |
Why?
|
| Exercise Tolerance | 1 | 2013 | 48 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2013 | 252 | 0.030 |
Why?
|
| Lysosomes | 1 | 2013 | 104 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 391 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2013 | 295 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2013 | 132 | 0.030 |
Why?
|
| Cell Death | 1 | 2013 | 256 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2013 | 493 | 0.030 |
Why?
|
| Male | 4 | 2018 | 40965 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 425 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 239 | 0.020 |
Why?
|
| Biological Transport | 1 | 2011 | 396 | 0.020 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2010 | 26 | 0.020 |
Why?
|
| Hyaluronan Receptors | 1 | 2010 | 36 | 0.020 |
Why?
|
| Radiation Pneumonitis | 1 | 2010 | 21 | 0.020 |
Why?
|
| Indocyanine Green | 1 | 2010 | 22 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2010 | 64 | 0.020 |
Why?
|
| Surface Properties | 1 | 2010 | 130 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 82 | 0.020 |
Why?
|
| Cell Movement | 1 | 2013 | 758 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2010 | 287 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1961 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 458 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 552 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 1749 | 0.020 |
Why?
|
| Polymethyl Methacrylate | 1 | 2007 | 12 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 1169 | 0.020 |
Why?
|
| Fibrosarcoma | 1 | 2007 | 84 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 1056 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2013 | 1578 | 0.020 |
Why?
|
| Extremities | 1 | 2007 | 167 | 0.020 |
Why?
|
| Osteosarcoma | 1 | 2007 | 158 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1196 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 1939 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 2468 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2010 | 1924 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 1135 | 0.020 |
Why?
|
| Prognosis | 1 | 2011 | 3679 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 3362 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 5210 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2011 | 8489 | 0.010 |
Why?
|
| Aged | 1 | 2011 | 18415 | 0.010 |
Why?
|